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The delivery of blood-borne molecules conveying
metabolic information to neural networks that
regulate energy homeostasis is restricted by brain
barriers. The fenestrated endothelium of median
eminence microvessels and tight junctions between
tanycytes together compose one of these. Here, we
show that the decrease in blood glucose levels
during fasting alters the structural organization of
this blood-hypothalamus barrier, resulting in the
improved access of metabolic substrates to the
arcuate nucleus. These changes are mimicked
by 2-deoxyglucose-induced glucoprivation and
reversed by raising blood glucose levels after fasting.
Furthermore, we show that VEGF-A expression in ta-
nycytes modulates these barrier properties. The
neutralization of VEGF signaling blocks fasting-
induced barrier remodeling and significantly impairs
the physiological response to refeeding. These
results implicate glucose in the control of blood-
hypothalamus exchanges through a VEGF-depen-
dent mechanism and demonstrate a hitherto
unappreciated role for tanycytes and the permeable
microvessels associated with them in the adaptive
metabolic response to fasting.
INTRODUCTION
Appetite, energy balance, and metabolism are all controlled by
select neurons of the hypothalamic arcuate nucleus (ARH) (forCreviews, see Elmquist et al., 2005; Gao and Horvath, 2007; Levin
et al., 2011; Sawchenko, 1998). These interoceptive sensory
neurons participate in neural networks that sense circulating
factors such as glucose and adiposity hormones that signal
changes in metabolic state (Cowley et al., 2001, 2003; Dunn-
Meynell et al., 2002; Elias et al., 1999; Hill et al., 2010; Liu
et al., 2012). However, the physiological mechanisms that
control the access of these factors to ARH circuits and their
regulation in response to changes in feeding status remain
largely unexplored.
Molecular traffic between the periphery and the central
nervous system (CNS), including the hypothalamus, is restricted
by regulated interfaces, such as the blood-brain barrier (BBB),
composed of tight junctions between endothelial cells lining
brain microvessels (Neuwelt et al., 2011). The blood-cerebro-
spinal-fluid (CSF) barrier, a lesser-known interface, is composed
of tanycytes, specialized hypothalamic glia that line the floor of
the third ventricle, and microvessels of the median eminence
(ME), a circumventricular organ adjacent to the ARH (Mullier
et al., 2010). While the endothelial cells of the ME are unique in
being fenestrated, and are thus highly permeable to blood-borne
molecules, tight-junction complexes between adjacent tany-
cytes act as a physical barrier preventing their diffusion to the
rest of the brain via the CSF. Transcellular transport across the
blood-brain and blood-CSF barriers is usually mediated by satu-
rable carriers (Banks, 2006; Hawkins and Davis, 2005). However,
whether specific hypothalamic areas that regulate energy
balance, such as the ARH, directly access peripheral homeo-
static signals through the fenestrated microvessel plexus in the
adjacent ME is a matter of debate (Ciofi et al., 2009; Flier,
2004; Mullier et al., 2010).
Here we show that food deprivation, by inducing both tight-
junction-complex reorganization in tanycytes and the increased
fenestration and permeability of ME microvessel loops thatell Metabolism 17, 607–617, April 2, 2013 ª2013 Elsevier Inc. 607
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Hypothalamic Barriers in CNS Control of Feedingreach the ventromedial ARH (vmARH) (Ambach and Palkovits,
1979), leads to such direct access. Refeeding, glucose infusion,
the selective inhibition of vascular endothelial growth factor A
(VEGF-A) expression in tanycytes, and the manipulation of
VEGF signaling all reverse these structural changes and the re-
sulting ability of molecules to enter the ARH.
RESULTS
Fasting-Induced Plasticity of the Blood-Hypothalamus
Barrier
To investigate the role of blood-hypothalamus barrier (BHB)
plasticity in the adaptive response to fasting, we compared the
hypothalami of mice deprived of food for 24 hr and those fed
ad libitum using immunofluorescence for two constitutive tight-
junction proteins, zonula occludens-1 (ZO-1) and occludin, ex-
pressed in BBB endothelial cells and tanycytes, and claudin-1,
expressed in tanycytes at the blood-CSF barrier (Mullier et al.,
2010). In parallel, antibodies to MECA-32 were used to selec-
tively label the fenestral diaphragms ofME endothelial cells (Ciofi
et al., 2009; Mullier et al., 2010).
Fasting increased the organization of tanycytic tight-junction
complexes in both the ME and ARH (Figures 1A and 1B and
Figure S1A available online), but not in standard non-ARH hypo-
thalamic vessels composing the BBB (Figure S1B). Fasting
intensified the honeycomb-like pattern of ZO-1 and occludin
around the apical pole of tanycytes overlying the ME (Figure 1A,
insets 2 and 5; Figure S1A, insets 3 and 6), and switched ZO-1
and occludin distribution from a diffuse apical pattern to a honey-
combpattern in tanycytes lining the third ventricle (3V) next to the
ARH (Figure 1A, insets 1 and 4; Figure S1A, insets 2 and 5).
Claudin-1 expression in ARH tanycytes also became organized
in food-deprived mice (Figures 1C and 1D). This reorganization
was associated with increased protein levels of ZO-1, but not
of occludin or claudin-1, in fasting animals (Figure S1D). Finally,
food-deprived mice refed for an additional 24 hr displayed a re-
appearance of the hypothalamic barrier phenotype of fed mice
(Figures 1B–1D).
In fasting mice, ME microvessel loops, some of which extend
up to the ARH, also demonstrated amarked increase in fenestra-
tion associatedwith changes inMECA-32 distribution (Figure 1A,
insets 1 and 4; Figure 1B) and the appearance of fenestrated dia-
phragms at the ultrastructural level (Figure 1E, inset 2;
Figure S1C). Western blotting revealed that this increased fenes-Figure 1. Fasting-Induced Fenestration of ME Microvessel Loops Rea
Tanycytes
(A) Vimentin (white), zonula occludens-1 (ZO-1, green), and MECA-32 (red) immu
fastingmice. Tanycytic tight-junction complexes exhibit a diffuse pattern (arrowhe
and a honeycomb pattern (empty arrowheads, insets 2, 4, and 5) when interactin
(B) MECA-32-positive microvessel loop number and ZO-1-positive tight-junction
group).
(C) Distribution of claudin-1 (arrows, green) in coronal sections of the hypothalam
(D) Proportion of the ventricular wall facing the ARH immunolabeled for claudin-
(E) Electron micrographs from fasting mice showing ARH capillaries with nonf
n, neuronal cell bodies; t, tanycyte cell bodies. The scale bar represents 10 mm (
(F) Real-time PCR and immunoblotting for MECA-32 and actin frommicrodissecte
per group).
***p < 0.001, **p < 0.01, *p < 0.05, fasting versus fed and refed groups. DMH, dorso
Figure S1.
Ctration was accompanied by a significant increase in MECA-32
protein levels (p < 0.05; Figure 1F). Together, the fasting-induced
structural reorganization of the tight-junction complexes of tany-
cytes lining the ventricular wall adjoining the ARH potentially
limits paracellular diffusion between the tissue and the CSF,
while ME microvessels simultaneously become more leaky.
These reversible morphological alterations at the BHB suggest
that nutritional state modulates the access of metabolic signals
from the periphery to ARH neurons critical for energy
homeostasis.
Glucose Deprivation Mediates Fasting-Induced
Plasticity at the BHB
What nutritional factors underlie these profound morphological
changes in fasting mice? Blood glucose acts as a metabolic
signal that can alter the activity of hypothalamic neurons (Levin
et al., 2011; Thorens and Larsen, 2004) and evokes robust
signaling in tanycytes, which act as glucosensors (Frayling
et al., 2011), suggesting that reduced glucose levels could
underlie the morphological changes seen during fasting. As ex-
pected, blood glucose levels were significantly lower after
24 hr of food deprivation (Figure 2A, p < 0.001). Levels were
normalized and fasting-induced BHB reorganization was pre-
vented (Figure 2B) by intravenous (i.v.) glucose (30%, 1–3 ml/min;
n = 6) but not saline infusion (n = 4). On the other hand, central
neuroglucopenia induced by the intraperitoneal (i.p.) or intracer-
ebroventricular (i.c.v.) injection of 2-deoxy-D-glucose (2-DG,
300 mg/kg i.p. or 1 mg/mouse i.c.v.; n = 4 each; Figures 2B
and S2A), a glucose analog that inhibits glucose metabolism
but can act on tanycytes (Frayling et al., 2011), caused the reor-
ganization of tanycytic tight-junction complexes and associated
microvessel loops to resemble those in fasting mice. The central
detection of glucose deprivation thus appears to play a key role
in BHB reorganization after fasting.
VEGF Promotes Changes in ME Microvessel Loops and
Tanycytic Tight-Junction Complexes during Fasting
Quantitative RT-PCR analyses showed that fasting induced
a constellation of hypothalamic transcripts involved in controlling
the structural plasticity of the brain (Figure 2C). However, only
VEGF-A expression was upregulated in both fasting and 2-DG-
treated animals (Figure 2C). VEGF protein levels increased in
the hypothalamus of 24-hr-fasting mice when compared to fed
mice (p < 0.05; Figure 2D), and 2-DG-treatment for 12 hr directlyching the ARH, and Tight-Junction-Complex Reorganization in ARH
noreactivity in coronal sections of the hypothalamic tuberal region in fed and
ads, inset 1) when interacting with ZO-1-positive blood vessels (arrows, inset 1)
g with MECA-32-positive vessels (empty arrows, insets 3, 4, and 6).
-complex density in the ME and ARH according to nutritional status (n = 4 per
ic tuberal region in fed, fasting and refed mice.
1 (n = 4 per group).
enestrated (arrow, inset 1) and fenestrated endothelia (arrowheads, inset 2).
1 mm in insets).
d ME andMBH explants containing the ARH from fed and fasting mice (n = 3–4
medial nucleus of the hypothalamus. Values shown aremeans ± SEM. See also
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Figure 2. Fasting-Induced BHB Plasticity Is Mediated by Glucose Deprivation and Tanycytic VEGF-A Expression
(A) Blood glucose levels in fed and fasting mice (n = 6 per group).
(B) Structural changes at the blood-CSF barrier in fasting mice infused with glucose (Glc; n = 6) or not (n = 6) and fed mice treated i.p. with 2-DG in the presence
(n = 4) or absence of Axitinib (Axi; n = 4) compared to vehicle-treated fed mice (n = 3).
(C) Real-time PCR analysis of genes involved in brain plasticity and glucosensing in the MBH of fasting and 2-DG-treated mice, normalized to values in mice fed
ad libitum (red line) (n = 4 per group).
(D) VEGF accumulates in the ME and MBH of fasting mice, as seen by immunoblotting (n = 3 per group).
(E) 2-DG application to ME/vmARH explants increases VEGF secretion when compared to vehicle (red line) (n = 4 per group).
(F) Quantification of MECA-32 and ZO-1 immunolabeling in fasting wild-type or VegfaloxP/loxP mice infused i.c.v. with Axitinib (n = 4) or tat-cre recombinant protein
(n = 4) and fed mice treated with VEGF (n = 4) or vehicle (n = 10).
(legend continued on next page)
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(p < 0.05; Figure 2E). We therefore treatedmice for 24 hr with Ax-
itinib (25mg/kg/12h, i.p. or 70 mg/mouse, i.c.v.), a tyrosine kinase
inhibitor that selectively inhibits VEGF receptors 1, 2, and 3
(VEGFR1, VEGFR2, and VEGFR3) (Mancuso et al., 2006). Axitinib
reversed both fasting- and 2-DG-evoked changes in tight-junc-
tion-complex organization in tanycytes and the associated mi-
crovessel loops in the ME/ARH region (Figures 2B, 2F, S2A,
and S2B). Conversely, VEGF infusion (60 mg/kg/12 hr, i.p. or
100 ng/mouse, i.c.v.) for 24 hr mimicked the effects of fasting
on BHB plasticity in fed mice (Figures 2F, 2G, and S2B) without
affecting tight-junction organization in BBB capillaries
(Figure S1B).
Next, we examined the contribution of VEGFR1, VEGFR2, and
VEGFR3, which are all expressed in the mediobasal hypothal-
amus (MBH; Figure S2C), to fasting-induced BHB plasticity, by
administering selective neutralizing monoclonal antibodies to
each receptor (40 mg/kg, i.p.) (Pytowski et al., 2005; Wang
et al., 2004). While antibodies to VEGFR1 and VEGFR3 bound
to both hypothalamic BBBmicrovessels and theMEmicrovessel
plexus, antibodies to VEGFR2 bound only to the latter
(Figure S2D). Importantly, the blockade of VEGFR2 and, to
a lesser extent, VEGFR1, inhibited the BHB rearrangement
observed after fasting (Figures S2E and S2F), while antibodies
to VEGFR3 had no effect on this plasticity (Figure S2F). Together,
these data suggest that increased hypothalamic VEGF levels
during food deprivation target VEGFR1 and VEGFR2 in ME
endothelial cells to promote microvessel permeability and
tight-junction-complex reorganization in the ME and ARH.
Fasting-Induced BHB Plasticity Requires Tanycytic
VEGF-A Expression
VEGF-A messenger RNA (mRNA) expression in the hypotha-
lamic tuberal region is restricted to tanycytes (Allen Brain Atlas,
http://mouse.brain-map.org/experiment/show/74988747; Fig-
ure S3A), suggesting that these cells play a role in the control
of VEGF-mediated BHB plasticity. Cell-sorting experiments
with tdTomatoloxP/+ reporter mice in which the tat-cre fusion
protein, whose cellular uptake is enhanced compared to cre re-
combinase (Peitz et al., 2002), was stereotaxically infused into
the third ventricle, where it selectively targeted tanycytes
(Figure S2G), were used to study fasting-dependent changes
in tanycytic gene expression in vivo (Figure 2H). Sorted
Tomato-positive cells abundantly expressed the tanycytic
marker DARPP-32 (Ho¨kfelt et al., 1988), which was barely
detectable in Tomato-negative cells (Figure S2I). Purified tany-
cytes also expressed GLUT1, GLUT2, and glucokinase tran-
scripts, as suggested by others (Rodrı´guez et al., 2005), and
low levels of VEGFR1 and VEGFR2, although VEGFR3 was
undetectable (Figure S2I). Intriguingly, fasting upregulated
VEGF-A but not VEGF-B or VEGF-C mRNA expression in tany-
cytes (Figures 2H and S2J), with a concomitant increase in the
transcript for hypoxia-inducible factor 1 alpha (HIF-1a) (Fig-(G) MECA-32 (red) and ZO-1 (green) immunolabeling in fasting mice and fed mice
the ependymal layer of the ME (arrows). Arrowheads, MECA-32-positive intrainfu
(H) Tanycyte isolation by FACS and real-time PCR analysis of VEGF-A mRNA in To
(n = 4 each).
***p < 0.001, **p < 0.01, *p < 0.05, various treatment groups versus untreated fe
Cure S2K), recently shown to be involved in hypothalamic gluco-
sensing (Zhang et al., 2011) and known to promote VEGF
expression (Carmeliet et al., 1998). Finally, Vegfa deletion in tany-
cytes by tat-cre infusion into the third ventricle of VegfaloxP/loxP
mice (Figure S3A) abolished fasting-induced BHB reorganization
(n = 4; Figure 2F) but did not affect BHB properties in animals fed
ad libitum (n = 4; data not shown). Together, these data demon-
strate that tanycytic VEGF-A expression plays a key role in regu-
lating fasting-induced BHB plasticity.
BHB Plasticity Modulates the Access of Blood-Borne
Metabolic Factors to the ARH
To establish whether the morphological changes described in
the MBH above were associated with altered permeability and
access of blood-borne molecules to the ARH, the extravasation
of intravenously injected Evans Blue dye frombrainmicrovessels
into the hypothalamus was compared between 24-hr-fasting
and fed mice. In fed mice, Evans Blue diffusion was restricted
to the vascular bed of hypothalamic BBB microvessels and the
ME (Figure 3A, top panels) and did not spread to neighboring
structures such as the ARH. In striking contrast, in 24-hr-fasting
mice, the dye was observed in the ventromedial ARH (vmARH),
where plastic BHB changes were observed in previous experi-
ments (Figures 3A and 3B). As with the morphological changes,
refeeding reversed dye diffusion into the vmARH (Figure 3B).
Importantly, fasting did not promote dye extravasation from
the intrinsic hypothalamic microvessels that compose the BBB
(Figure S3B). The inhibition of BHB reorganization in food-
deprived mice by Axitinib, VEGFR2-neutralizing antibodies,
Vegfa gene targeting, or glucose infusion prevented dye diffu-
sion into the ARH, whereas the induction of barrier plasticity
with VEGF in fed mice clearly elicited such diffusion (Figure 3B).
These findings strongly suggest that the anatomical changes at
the BHB in fasting animals facilitate the access of blood-borne
signals to the vmARH due to its increased permeability.
To directly test whether fasting-induced structural rearrange-
ments at the BHB do indeed increase the access of critical meta-
bolic substrates to the ARH, we simultaneously assessed
glucose levels in the ARH and the adjacent ventromedial nucleus
of the hypothalamus (VMH) by microdialysis in fed or 24-hr-fast-
ing rats (Figure 3C). First, rats exhibited similar fasting-induced
morphological and functional changes to the BHB as did mice
(Figure S3C–S3E). While ARH glucose levels in fed rats were
comparable to those in the VMH (Figure 3C), in 24-hr-fasting
rats, ARH glucose levels were 300%higher than VMH levels (Fig-
ure 3C). In keeping with the restricted occurrence of microves-
sels whose permeability changes in response to feeding status
in the vmARH, and unlike what would have been expected if
the BBB were completely permeable throughout the ARH, ARH
glucose levels during fasting (z2 mM) never reached blood
levels (z5 mM). However, these data do suggest that fasting-
induced structural changes at the BHB create a privileged route
for the access of circulating glucose to glucosensing ARHtreated with VEGF or vehicle. Long MECA-32-positive microvessel loops reach
ndibular loop reaching the ARH.
mato-positive (pos; tanycytes) and -negative cells (neg) in fed and fasting mice
d mice. Values shown are means ± SEM. See also Figures S2 and S3.
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Figure 3. Fasting-Induced Structural Changes at the BHB Facilitate the Access of Blood-Borne Metabolic Signals to the ARH
(A) Evans Blue dye diffusion (gray) and MECA-32 (red) and ZO-1 (green) immunolabeling in the hypothalamic tuberal region in fed and fasting mice.
(B) Quantification of Evans Blue diffusion into the ARH in fasting mice infused with Axitinib (n = 4) or glucose (Glc; n = 5), food-deprived tat-cre-treated
VegfaloxP/loxP mice (n = 4), fed VEGF-treated mice (n = 5), food-deprived mice after refeeding for 24 hr (Refed; n = 4), and vehicle-treated fed mice (n = 7).
(legend continued on next page)
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(Figure 3F).
We further explored this hypothesis by examining the ability of
exogenous leptin, a 16 kDa peptide hormone, to access ARH
neurons by quantifying the leptin-stimulated phosphorylation of
STAT3 in fasting and fed mice. Leptin (3 mg/kg, i.p.) induced
a 30% increase in immunoreactivity for phosphorylated STAT3
(pSTAT3) in food-deprived mice when compared to fed mice
(Figure 3D). This increase was restricted to the vmARH (Fig-
ure S3F). Axitinib (which inhibits BHB rearrangement; Figure 2F)
prevented the leptin-induced increase in pSTAT3 in fasting
animals (Figures 3D and 3E). Conversely, the treatment of fed
mice (in which endogenous leptin levels are significantly higher
than in fasting mice; Figure S3G), with VEGF, which promotes
BHB reorganization (Figures 2F and 2G), markedly increased
STAT3 activation in the ARH (Figures 3D and 3E). This effect
was blunted by the i.p. injection of a mutated recombinant leptin
antagonist (LAN; 3 mg/kg) that is devoid of biological activity but
effectively binds to the leptin receptor (Niv-Spector et al., 2005)
45 min before death (Figures 3D and 3E), suggesting that leptin
access to the ARH is facilitated by VEGF treatment in fed mice.
Together, these data suggest an important role for BHBplasticity
in modulating the access of metabolic factors to the ARH.
BHB Plasticity Modulates Feeding
To evaluate the functional consequences of BHB plasticity to
feeding behavior, we measured refeeding after fasting in control
and Axitinib-treated mice. Compared to vehicle-infused mice
refed after a 24 hr fast, food intake was significantly lower in Ax-
itinib-treated refed mice (Figure 4A). This difference, which
occurred primarily during the first 30min of refeeding (Figure 4A),
was associated with decreased body weight gain 24 hr and 48 hr
after Axitinib administration (Figure 4B). Importantly, Axitinib
alone did not inhibit food intake in animals fed ad libitum (Fig-
ure 4A), suggesting that reduced feeding in fasting mice was
not due to food aversion. Conversely, food intake significantly
increased in the afternoon and at lights-off (when endogenous
anorectic hormones are thought to stimulate food intake) in fed
mice 24 hr after the initiation of VEGF treatment, when compared
to vehicle-treated mice (Figure 4C). Subsequently, we found that
theanorectic andweight-loss-inducing effects of exogenous lep-
tin were greater in fed mice treated with VEGF than in vehicle-
treated controls (Figure 4D). Together, these findings suggest
that VEGF-mediated structural changes at the BHB, by modu-
lating the access of blood-borne metabolic substrates to the
ARH, play an important role in the adaptive response to fasting.
DISCUSSION
Energy homeostasis requires increased food intakewhen energy
stores are depleted and a means of signaling this depletion to(C) Placement of microdialysis cannulae (upper panel) for the simultaneous meas
bar graph (lower panel; n = 4–5 per group).
(D) Distribution of pSTAT3 immunoreactivity (white) in coronal sections of the ARH
administration of leptin (n = 4 per group), LAN (n = 3), or vehicle (n = 3–4 per gro
(E) Quantification of pSTAT3 immunoreactive cells.
(F) Structural differences between the ME and ARH of mice fed ad libitum and fast
***p < 0.001, **p < 0.01, *p < 0.05, various treatment groups versus untreated fe
Ccentral neurons that control feeding behavior (Cowley et al.,
2001, 2003; Dunn-Meynell et al., 2002; Elias et al., 1999; Liu
et al., 2012), such as ARH neurons (Hill et al., 2010). Here, we
provide evidence that the BHB (Mullier et al., 2010) undergoes
dynamic and reversible structural changes that modulate its
permeability in response to glucose and tanycytic VEGF levels,
thereby acting as a checkpoint in the access of peripheral meta-
bolic signals to ARH neurons.
Our data show that fasting-evoked dips in blood glucose
levels trigger VEGF-A expression in tanycytes and VEGF accu-
mulation in the hypothalamic ME, which acts via VEGFR to
promote endothelial cell fenestration. Tanycytes contacting
these newly permeable microvessel loops then reorganize their
tight-junction complexes to seal the paracellular space between
the parenchyma and the CSF. In consequence, some target
neurons in the vmARH are no longer insulated by the blood-
brain and blood-CSF barriers but become directly exposed to
peripheral metabolic signals (Figure 3F), a situation reversed
upon refeeding. This increased accessibility is confirmed both
by the leakage of intravenously injected dye into the vmARH
and by higher physiological glucose levels in the ARH than in
the adjacent VMH in the fasting state. Fasting-induced reorga-
nization is blocked by the VEGFR inhibitor Axitinib, which,
consistent with the importance of these changes in the adaptive
response to fasting, reduces food intake and weight gain when
food-deprived mice are refed. Even though Axitinib alone did
not affect food intake in control animals fed ad libitum, chronic
Axitinib treatment, which causes a marked reduction in endo-
thelial cell fenestration (Kamba et al., 2006), is known to affect
glucose homeostasis (Kamba et al., 2006) and to lead to
decreased appetite and weight loss in patients (Fruehauf
et al., 2011; Rini et al., 2009).
Conversely, triggering BHB permeability in mice fed ad libitum
with exogenous VEGF, which signals food deprivation, signifi-
cantly increases their food intake and sensitivity to the anorectic
effects of leptin. We used leptin as a surrogate for other large
metabolic peptides such as ghrelin because we could assess
its access to the vmARH by monitoring the activation of
STAT3. In fact, leptin levels are decreased during fasting, leading
to a marked anabolic state within the hypothalamus, with
increased neuropeptide Y and agouti-related peptide (AgRP)
and decreased proopiomelanocortin levels. This combination
acts as a potent stimulus for the animal to seek and ingest
food. Contrarily, ghrelin levels increase during fasting, and the
increased permeability of ARH microvessels to this peptide
could facilitate its selective activation of anabolic AgRP neurons
(Elmquist et al., 2005; Gao and Horvath, 2007; Levin et al., 2011;
Sawchenko, 1998).
Falling blood glucose levels and decreased glucose metabo-
lism appear to be critical signals for the initiation of the BHB
response to starvation. Glucose replacement prevents thisurement of ARH and VMH glucose levels in fed and fasting rats, reported in the
in fed and fasting mice treated or not with VEGF and Axitinib (Axi) after the i.p.
up).
ing mice and their effects on the diffusion of blood-borne signals into the brain.
d mice. Values shown are means ± SEM. See also Figure S3.
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Figure 4. BHB Plasticity Modulates Feeding Behavior
(A) Cumulative and absolute food intake in fasting mice with or without i.p. Axitinib injection (orange; n = 4 per group) during refeeding after a 24 hr fast and in
vehicle-treated (gray; n = 4) or Axitinib-treated mice (gray and yellow stripes; n = 3–4) fed ad libitum.
(B)Bodyweight gainduring thefirst48hrof refeeding inmicepreviously food-deprived for 24hr, and thatwere (orange;n=4) or not treatedwithAxitinib (black; n=4).
(C) Absolute food intake in mice fed ad libitum infused with VEGF (purple; n = 3) or not (gray; n = 4) for 3 days.
(D) Anorectic and weight-loss-inducing effects of leptin and vehicle in mice fed ad libitum subjected to VEGF treatment or not (n = 10 per group).
***p < 0.001, **p < 0.01, *p < 0.05, various treatment groups versus untreated fed mice. Values shown are means ± SEM.
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duces it. The molecular pathways that underlie the subsequent
accumulation of VEGF in the ME are unknown. However, our
results showing that VEGF-A inactivation in these cells blunts
fasting-induced BHB plasticity strongly suggest that they are
intrinsic to tanycytes, which directly and rapidly respond to
changes in glucose levels (Frayling et al., 2011). This response
could involve HIF-1a, which is upregulated in tanycytes by fast-
ing (Figure S2J), and is known to be activated by glucoprivation
and to promote VEGF expression (Carmeliet et al., 1998; Zhang
et al., 2011).
VEGF has long been associated with increased vascular
permeability (Esser et al., 1998; Ioannidou et al., 2006) and is
required for ependymal cell function and the maintenance of
key brain-periphery interfaces such as the choroid plexus614 Cell Metabolism 17, 607–617, April 2, 2013 ª2013 Elsevier Inc.(Maharaj et al., 2008). VEGF might also contribute to increased
BBB permeability in diseased (Argaw et al., 2009) but not healthy
brains (Hawkins et al., 2010) (Figure S1B and S3A). Our data
suggest that VEGF and its signaling receptor, VEGFR2, are key
determinants of fasting-induced structural rearrangements at
the BHB. Although VEGF involvement in endothelial cell fenes-
tration and the expression of diaphragm proteins (named PV-1
in rats and MECA-32 in mice) is clearly documented (Esser
et al., 1998; Kamba et al., 2006), the mechanisms underlying
tight-junction-complex remodeling in tanycytes, which express
low levels of VEGFR2, are unknown. These could also involve
VEGF signaling, which induces posttranslational modifications
in tight-junction proteins under some pathological conditions
(Murakami et al., 2009), or other as-yet-undiscovered signals
released by endothelial cells upon fenestration.
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is modified in tanycytes under fasting conditions, could also be
involved in brain metabolic sensing and body-weight regulation.
Occludin-null mice are leaner than their wild-type littermates
(Saitou et al., 2000), and the i.c.v. infusion of antisense oligo-
deoxynucleotides to occludin restores leptin sensitivity in an
animal model of diet-induced leptin resistance and hypergly-
cemia (Oh-I et al., 2005) in which fasting appears not to promote
changes in BHB permeability (unpublished data). This, together
with recent findings showing that a high-fat diet triggers neuro-
genic activity in ME tanycytes (Lee et al., 2012), shows that these
cells play a dynamic role in metabolic sensing and hold thera-
peutic potential in metabolic disorders.
Overall our data unveil a new physiological concept in the
maintenance of energy homeostasis, in which blood glucose
levels, by regulating tanycytic VEGF-A expression, modulate
the organization of their tight junctions aswell as the permeability
of ME capillary loops in the vmARH, and thereby control the
access of circulating homeostatic signals to brain circuits that
regulate metabolism.EXPERIMENTAL PROCEDURES
Animals
Male C57Bl/6 mice, 3–4 months old (Charles River) and male Sprague Dawley
rats (Charles River) were given ad libitum access to water and standard labo-
ratory chow. tdTomatoloxP/+ reporter mice were purchased from the Jackson
Laboratories (Bar Harbor, ME) and VegfaloxP/loxP mice (Gerber et al., 1999)
were a gift from N. Ferrara (Novartis). Animal studies were approved by the
Institutional Animal Care and Use Committee of Lille and the East Orange
Veterans Affairs Medical Center.
Treatment Protocols
Glucose Infusion and 2-DG Injection
Mice fed ad libitum and fasting mice were anesthetized with isoflurane and the
jugular vein catheterized. After a 7 day recovery period, fed mice were infused
with saline solution (0.9%) for 24 hr while fasting mice were infused with
glucose (30% in saline) or saline. Moreover, mice fed ad libitum were given
an i.p. or i.c.v. injection of 2-DG (RDS) in saline or an equal volume of saline
alone, following procedures described previously (Mullier et al., 2010).
Anti-VEGF and VEGF Treatments
Mice were subjected to an i.p. or i.c.v. infusion of Axitinib (in DMSO, LC Labo-
ratories, France) or an equal volume of DMSO during the 24 hr fasting period.
Finally, mice fed ad libitum were given an i.p. or i.c.v. infusion of recombinant
mouse VEGF 164 (RDS) in PBS for 24 hr.
Tat-Cre Delivery
A tat-cre fusion protein produced as detailed previously (Peitz et al., 2002) was
stereotaxically infused into the third ventricle (1.5 ml over 5 min at 2.1 mg/ml;
anteroposterior, 1.7 mm; midline, 0 mm; dorsoventral, –5.6 mm) of isoflur-
ane-anesthetized floxed mice 24 hr before experiments.
Fluorescence-Activated Cell-Sorting and Real-Time PCR Analyses
Tomato-positive cells were sorted and collected from ME explants microdis-
sected from fasting and fed mice and processed for quantitative RT-PCR,
as described in the Supplemental Experimental Procedures.
Physiological Measurements
Food Intake
Mice were housed three per cage with preweighed amounts of food
dispensed through the wire cage tops, and food intake was measured every
30 min for the first 3 hr and every hour for 24 hr. The average and cumulative
food intake of three mice was used for statistical comparisons (n = 4 cages
per group).CIn Vivo Leptin Sensitivity Test
Micewere housed in individual cages 2 days before the beginning of the exper-
iment. Mice fed ad libitum and fed mice infused with VEGF were injected i.p. at
6:00 p.m. with vehicle (5 mM sodium citrate buffer, pH 4.0) or leptin (3 mg/kg,
PeproTech). Body weight and food consumption were measured at 8:00 a.m.
the next day.
Permeability Assays, Immunohistochemistry, and Image Analysis
Mice were given i.v. injections of sterile 1% Evans Blue dye (Sigma) in 0.9%
saline (50 ml) into the tail vein and killed by decapitation 20 min later. Brains
were processed for immunofluorescence as described previously (Mullier
et al., 2010). The primary antibodies used were as follows: polyclonal rabbit
anti-zonula occludens-1 (ZO-1, 1:500, Zymed), rabbit anti-claudin-1 (1:200,
Zymed), chicken anti-vimentin (1:2,000, Chemicon), and rat anti-MECA-32
(1:200, gift from Professor Britta Engelhardt, Switzerland). Additional details
appear in the Supplemental Experimental Procedures and Figure S4.
For pSTAT3 immunolabeling and analysis, mice were injected i.p. with
vehicle (5 mM sodium citrate buffer, n = 4 per group), leptin (PeproTech), or
LAN (Protein Laboratories Rehovot, Israel) and perfused 45 min later with
a 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were pro-
cessed for pSTAT3 immunolabeling and quantification as described previ-
ously (Bouret et al., 2012). Additional details appear in the Supplemental
Experimental Procedures.
Microdialysis of the Hypothalamus
Placement of hypothalamic cannulae and the assessment of ARH and VMH
glucose levels in male rats (n = 9) was performed as described previously
(Dunn-Meynell et al., 2009) and detailed in the Supplemental Experimental
Procedures.
Immunoblotting
Frozen microdissected ME and MBH of mice fed ad libitum (n = 3) and those
fasting for 24 hr (n = 3) were immunoblotted as described in the Supplemental
Experimental Procedures. Rabbit anti-claudin-1 (1:1000, Zymed), mouse anti-
VEGF (1:500, Santa Cruz), rat anti-MECA-32 (1:500, Santa Cruz) and goat anti-
actin antibodies (1:500, Santa Cruz) were used in these experiments.
Statistical Analysis
All values are expressed as means ± SEM. Data were analyzed for statistical
significance with SigmaPlot software (Version 11.0), using one-way or two-
way ANOVA followed by a Tukey post hoc test when appropriate. p values
of less than 0.05 were considered to be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures, and Supplemental References can be found with this
article online at http://dx.doi.org/10.1016/j.cmet.2013.03.004.
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